Acute effects of nalmefene on LH, prolactin, and testosterone in male rhesus monkeys

Pharmacology Biochemistry and Behavior

Volumn 66, Issue 2, 2000, Pages 275-283

  Mello, Nancy K ^a   Mendelson, Jack H ^a   Kelly, Maureen ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Luteinizing hormone; Nalmefene; Opioidantagonist; Prolactin; Testosterone

Indexed keywords

LUTEINIZING HORMONE; NALMEFENE; PLACEBO; PROLACTIN; TESTOSTERONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HORMONE BLOOD LEVEL; HORMONE RELEASE; MALE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY;

ANIMALS; HYPOTHALAMUS; KINETICS; LUTEINIZING HORMONE; MACACA MULATTA; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PITUITARY GLAND; PROLACTIN; TESTOSTERONE;

MACACA MULATTA;

EID: 0034045604     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(00)00190-8     Document Type: Article

References (51)

1. Armeanu M.C., Berkhour G.M.J., Schoemaker J. Pulsatile luteinizing hormone secretion in hypothalamic amenorrhea, anorexia nervosa, and polycystic ovarian disease during naltrexone treatment. Fertil. Steril. 57:1992;762-770.
2. Bardin C. Pituitary-testicular axis. Yen S., Jaffe R. Reproductive endocrinology. 2nd ed:1986;177-199 W. B. Saunders Co, Philadelphia.
3. Ben-Jonathan N. Dopamine. A prolactin-inhibiting hormone Endocr. Rev. 6:1985;564-589.
4. Billington C.J., Shafer R.B., Morley J.E. Effects of opioid blockade with nalmefene in older impotent men. Life Sci. 47:1990;799-805.
5. Cameron J.L., Nosbisch C. Suppression of pulsatile luteinizing hormone and testosterone secretion during short term food restriction in the adult male rhesus monkey (Macaca mulatta). Endocrinology. 128:1991;1532-1540.
6. Couzinet B., Young J., Brailly S., Chanson P., Schaison G. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 80:1995;2102-2107.
7. Crowley W.F. Role of endogenous opioid peptides in the physiological regulation of luteinizing hormone and prolactin secretion. Negro-Vilar A., Conn P.M. Peptide hormones. Effects and mechanisms of action:1988;79-118 CRC Press, Boca Raton, FL.
8. De Wit W., Schoute E., Schoemaker J. Chronic naltrexone treatment induces desensitization of the luteinizing hormone pulse generator for opioid blockade in hyperprolactinemia patients. J. Clin. Endocrinol. Metab. 80:1996;1739-1742.
9. Dixon R., Howes J., Gentile J., Hsu H.B., Hsiao J., Garg D., Weidler D., Meyer M., Tuttle R. Nalmefene. Intravenous safety and kinetics of a new opioid antagonist Clin. Pharmacol. Ther. 39:1986;49-53.
10. Ellingboe J., Mendelson J.H., Kuehnle J.C. Effects of heroin and naltrexone on plasma prolactin levels in man. Pharmacol. Biochem. Behav. 12:1979;163-165.
11. Emmerson P.J., Liu M.-R., Woods J.H., Medzihradsky F. Binding affinity and selecivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmacol. Exp. Ther. 271:1994;1630-1637.
12. France C.P., Gerak L.R. Behavioral effects of 6-methylene naltrexone (nalmefene) in rhesus monkeys. J. Pharmacol. Exp. Ther. 270:1994;992-999.
13. Gal T.J., DiFazio C.A. Prolonged antagonism of opioid action with intravenous nalmefene in man. Anesthesiology. 64:1986;175-180.
14. Gilbeau P.M., Almirez R.G., Holaday J.W., Smith C.G. Opioid effects on plasma concentrations of luteinizing hormone and prolactin in adult male rhesus monkey. J. Clin. Endocrinol. Metab. 60:1985;299-305.
15. Glass P.S., Jhaveri R.M., Smith L.R. Comparison of potency and duration of action of nalmefene and naloxone. Anesth. Analg. 78:1994;536-541.
16. Gold M.S., Redmond D.E., Donabedian R.K. The effects of opiate agonist and antagonist on serum prolactin in primates. Possible role for endorphins in prolactin regulation Endocrinololgy. 105:1979;284-289.
17. Graves G.R., Kennedy T.G., Weick R.F., Casper R.F. The effect of nalmefene on pulsatile secretion of luteinizing hormone and prolactin in men. Hum. Reprod. 8:1993;1598-1603.
18. 131I labeled human growth hormone on high specific radioactivity. Biochem. J. 89:1963;114-123.
19. Hahn E.F., Fishman J., Heilman R.D. Narcotic antagonists 4. Carbon-6 derivative of N-substituted noroxymorphones as narcotic antagonists. J. Med. Chem. 18:1975;259-262.
20. Knobil E. The neuroendocrine control of the menstrual cycle. Rec. Prog. Horm. Res. 36:1980;53-88.
21. Matera C., Freda P.U., Ferin M., Wardlaw S.L. Effect of chronic opioid antagonism on the hypothalamic-pituitary-ovarian axis in hyperprolactinemia. J. Clin. Endocrinol. Metab. 80:1995;540-545.
22. McArthur J.W., Turnbull B.A., Pehrson J., Bauman M., Henley K., Turner A., Evans W.J. Nalmefene enhances LH secretion in a proportion of oligo-amenorrheic athletes. Acta Endocrinol. (Copenh.). 128:1993;325-333.
23. Mello N.K., Mendelson J.H. Cocaine's effects on neuroendocrine systems. Clinical and preclinical studies Pharmacol. Biochem. Behav. 57:1997;571-599.
24. Mello N.K., Mendelson J.H., Bree M.P., Skupny A. Naltrexone effects on pituitary and gonadal hormones in male and female rhesus monkeys. Pharmacol. Biochem. Behav. 31:1989;683-691.
25. Mello N.K., Sarnyai Z., Mendelson J.H., Drieze J.M., Kelly M. Acute effects of cocaine on anterior pituitary hormones in male and female rhesus monkeys. J. Pharmacol. Exp. Ther. 266:1993;804-811.
26. Mendelson J.H., Mello N.K., Cristofaro P., Skupny A., Ellingboe J. Use of naltrexone as a provocative test for hypothalamic-pituitary hormone function. Pharmacol. Biochem. Behav. 24:1986;309-313.
27. Mendelson J.H., Mello N.K., Teoh S.K., Ellingboe J. Use of naltrexone for the diagnosis and treatment of reproductive hormone disorders in women. Harris L.S. Problems of drug dependence 1990, DHHS Publ. No. (ADM)91-1753. 1991;161-167 U.S. Government Printing Office, Washington, DC.
28. Mendelson J.H., Mello N.K., Teoh S.K., Ellingboe J., Cochin J. Cocaine effects on pulsatile secretion of anterior pituitary, gonadal, and adrenal hormones. J. Clin. Endocrinol. Metab. 69:1989;1256-1260.
29. Michel M.E., Bolger G., Weissman B.A. Binding of a new opiate antagonist, nalmefene, to rat brain membranes. Methods Find. Exp. Clin. Pharmacol. 7:1985;175-177.
30. Midgley A.R. Radioimmunoassay. A method for human chorionic gonadotropin and human luteinizing hormone Endocrinology. 79:1966;10-18.
31. Norman R.L., Lindstrom S.A., Bangsberg D., Ellinwood W.E., Gliessman P., Spies H.G. Pulsatile secretion of luteinizing hormone during the menstrual cycle of rhesus macaques. Endocrinology. 115:1984;261-266.
32. O'Byrne K.T., Thalabard J.-C., Grosser P.M., Wilson R.C., Williams C.L., Chen M.D., Ladendorf D., Hotchkiss J., Knobil E. Radiotelemetric monitoring of hypothalamic gonadotropin-releasing hormone pulse generator activity throughout the menstrual cycle of the rhesus monkey. Endocrinology. 129:1991;1207-1214.
33. Physicians' Desk Reference, 51st ed.: Montvale, NJ: Medical Economics Company, Inc.; 1997.
34. Stewart J.K., Clifton D.K., Koerker D.J., Rogol A.D., Jaffe T., Goodner C.J. Pulsatile release of growth hormone and prolactin from the primate pituitary in vitro. Endocrinology. 116:1985;1-5.
35. Urban R.J., Evans W.S., Rogol A.D., Kaiser D.L., Johnson M.L., Veldhuis J.D. Contemporary aspects of discrete peak-detection algorithms. I. The paradigm of the luteinizing hormone pulse signal in men. Endocr. Rev. 9:1988;3-37.
36. Urban R.J., Johnson M.L., Veldhuis J.D. Biophysical modeling of sensitivity and positive accuracy of detecting episodic endocrine signals. Am. J. Physiol. 257:1989;E88-E94.
37. VanVugt D.A., Heisler L.E., Reid R.L. Progesterone inhibits the estrogen-induced gonadotropin surge in the rhesus monkey independent of endogenous opiates. J. Clin. Endocrinol. Metab. 74:1992;1312-1319.
38. VanVugt D.A., Webb M.Y., Reid R.L. Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey. Neuroendocrinology. 49:1989;275-280.
39. VanVugt D.A., Webb M.Y., Reid R.L. Naloxone antagonism of corticotropin-releasing hormone stimulation of prolactin secretion in rhesus monkeys. J. Clin. Endocrinol. Metab. 68:1989;1060-1066.
40. Veldhuis J., Rogol A.D., Samojilk E., Ertel N. Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man. J. Clin. Invest. 74:1984;47-55.
41. Veldhuis J.D., Johnson M.L. Cluster analysis. A simple, versatile and robust algorithm for endocrine pulse detection Am. J. Physiol. 250:1986;E486-E493.
42. Veldhuis J.D., Johnson M.L. Operating characteristics of the hypothalamo-pituitary-gonadal axis in men. Circadian, ultradian, and pulsatile release of prolactin and its temporal coupling with luteinizing hormone J. Clin. Endocrinol. Metab. 67:1988;116-123.
43. Veldhuis J.D., Rogol A.D., Johnson M.L. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man. J. Clin. Invest. 72:1983;2031-2040.
44. Wang C.F., Lasley B.L., Lein A., Yes S.S. The functional changes of the pituitary gonadotrophs during the menstrual cycle. J. Clin. Endocrinol. Metab. 42:1976;718.
45. Wang D.S., Sternbach G., Varon J. Nalmefene. A long-acting opioid antagonist. Clinical applications in emergency medicine J. Emerg. Med. 16:1998;471-475.
46. Wehrenberg W.B., Ferin M. Regulation of pulsatile prolactin secretion in primates. Biol. Reprod. 27:1982;99-103.
47. Wildt L., Leyendecker G. Induction of ovulation by the chronic administration of naltrexone in hypothalamic amenorrhea. J. Clin. Endocrinol. Metab. 64:1987;1334-1335.
48. Wildt L., Leyendecker G., Sir-Petermann T., Waibel-Treber S. Treatment with naltrexone in hypothalamic ovarian failure. Induction of ovulation and pregnancy Hum. Reprod. 8:1993;350-358.
49. Yen S.S.C. Studies of the role of dopamine in the control of prolactin and gonadotropin secretion in humans. Fuxe K., Hokfelt T., Luft R. Central regulation of the endocrine system. 1979;387-416 Plenum Press, New York.
50. Yen S.S.C. Prolactin in human reproduction. Yen S.S.C., Jaffe R.B. Reproductive endocrinology. 3rd ed:1991;357-388 W. B. Saunders Co, Philadelphia.
51. Yen S.S.C., Quigley M.E., Reid R.L., Ropert J.F., Cetel N.S. Neuroendocrinology of opioid peptides and their role in the control of gonadotropin and prolactin secretion. Am. J. Obstet. Gynecol. 152:1985;485-493.